Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TFP Block in Pediatric Inguinal Hernia Repair
NCT04272320Completed
- Sponsor
- Atatürk University
- Start
- Sep 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of bupivacaine in inguinal hernia (2 arms), sponsored by Atatürk University. Primary endpoint: Pain Score at 24 hours. Started Sep 2021; status: completed.
02
Drugs
bupivacaine
03
Conditions
inguinal hernia
Beyond the preview
Go deeper on NCT04272320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04272320.